MONOLITHIC POWER SYSTEMS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MONOLITHIC POWER SYSTEMS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $333.07M | Feb 29, 2016 |
| FY2015 | Dec 31, 2014 | $282.54M | Feb 29, 2016 |
| FY2015 | Dec 31, 2013 | $238.09M | Feb 29, 2016 |
| FY2013 | Dec 31, 2012 | 213.81M | Mar 10, 2014 |
| FY2014 | Dec 31, 2012 | $213.81M | Mar 2, 2015 |
| FY2013 | Dec 31, 2011 | $196.52M | Mar 10, 2014 |
| FY2012 | Dec 31, 2010 | $218.84M | Mar 5, 2013 |
| FY2011 | Dec 31, 2009 | $165.01M | Mar 12, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.79B | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | $737.18M | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | $664.57M | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | $637.55M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.21B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.82B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.79B | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $1.21B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $844.45M | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $166.74M | Feb 28, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $129.43M | Mar 1, 2018 |
| FY2017 | Sep 30, 2017 | $128.94M | Mar 1, 2018 |
| FY2017 | Jun 30, 2017 | $112.20M | Mar 1, 2018 |
| FY2017 | Mar 31, 2017 | $100.36M | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | $103.62M | Mar 1, 2018 |
| FY2017 | Sep 30, 2016 | $106.46M | Mar 1, 2018 |
| FY2017 | Jun 30, 2016 | $94.08M | Mar 1, 2018 |
| FY2017 | Mar 31, 2016 | $84.51M | Mar 1, 2018 |
| FY2016 | Dec 31, 2015 | $86.92M | Mar 1, 2017 |
| FY2016 | Sep 30, 2015 | $91.19M | Mar 1, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.54B | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | $406.23M | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | $366.02M | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | $353.23M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.22B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.02B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.05B | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $685.46M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $465.95M | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $91.94M | Feb 28, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $621.48M | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | $179.77M | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | $135.01M | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | $135.05M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.59B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $427.37M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $437.67M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $242.02M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $164.38M | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $32.44M | Feb 28, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $728.64M | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | $195.18M | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | $164.76M | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | $168.76M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $539.36M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $481.74M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $526.79M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $262.42M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $158.88M | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $30.69M | Feb 28, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | $44.52M | Mar 12, 2012 |
| FY2011 | Dec 31, 2010 | $44.37M | Mar 12, 2012 |
| FY2011 | Dec 31, 2009 | $38.30M | Mar 12, 2012 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $428.84M | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | $112.87M | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | $104.99M | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | $92.24M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $356.76M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $275.74M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $281.60M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $232.42M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $161.67M | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $33.24M | Feb 28, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $838.20M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $788.41M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $638.21M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $246.67M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $320.01M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $267.80M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $216.30M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $141.45M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $133.82M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $107.79M | Mar 1, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $172.01M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $146.12M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $57.58M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $58.84M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $94.42M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $55.61M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $95.81M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $22.53M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $65.77M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $37.11M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.19B | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | $4.11B | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | $3.87B | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | $3.71B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $3.52B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $2.43B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $2.06B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.59B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.21B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $956.38M | Mar 1, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $662.70M | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | $729.88M | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | $662.29M | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | $631.51M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $564.70M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $384.41M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $390.28M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $341.84M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $241.90M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $182.88M | Mar 1, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.53B | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | $3.38B | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | $3.21B | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | $3.07B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.95B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $2.05B | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | $1.67B | Feb 27, 2026 |
| FY2024 | Dec 31, 2021 | $1.24B | Mar 3, 2025 |
| FY2023 | Dec 31, 2020 | $966.59M | Feb 29, 2024 |
| FY2022 | Dec 31, 2019 | $773.49M | Feb 24, 2023 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.94M | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | $25.94M | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | $25.94M | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | $25.94M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $25.94M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $6.57M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $6.57M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $6.57M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $6.57M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $6.57M | Mar 1, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.61B | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | $2.51B | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | $2.41B | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | $2.35B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.29B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $947.06M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $716.40M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $424.88M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $298.75M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $229.45M | Mar 1, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.10B | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | $1.08B | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | $787.38M | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | $637.35M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $691.82M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $527.84M | Feb 27, 2026 |
| FY2023 | Dec 31, 2022 | $288.61M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $189.27M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $334.94M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $172.96M | Mar 1, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12 | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | 3 | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | 2 | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 32 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 8 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 9 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 5 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 3 | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 28, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12 | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | 3 | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | 2 | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 32 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 8 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 9 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 5 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 3 | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 28, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 48.71M | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | 47.91M | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | 47.89M | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | 47.88M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 47.82M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 48.03M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | 47.11M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 46.26M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | 45.27M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 43.62M | Mar 1, 2021 |